"...fundamentally it is overvalued at this
point in time......."
But that's just your opinion, not a fact.
In fact compared to biotechs in the US and the UK, it is very undervalued. And at the end of the day imu is on the world stage, not just the asx (where biotechs generally have a much lower mkt cap).
But that's all my opinion of course.
Ps. I personally don't mind posters posting different points of view.
Cheers
"...fundamentally it is overvalued at this point in time......."...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
-0.007(8.97%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 7.8¢ | 8.0¢ | 7.0¢ | $4.930M | 66.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 571382 | 7.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 1102836 | 5 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.007 ( 10.7 %) |
||||
| Open | High | Low | Volume | ||
| 7.8¢ | 8.0¢ | 7.0¢ | 28787854 | ||
| Last updated 15.59pm 19/04/2024 ? | |||||
| IMU (ASX) Chart |